AIMS: The metabolic syndrome and associated comorbidities, like diabetes, hypertension and obesity, have been implicated in the development of heart failure with preserved ejection fraction (HFpEF). The molecular mechanisms underlying the development of HFpEF remain to be elucidated. We developed a cardiome-directed network analysis and applied this to high throughput cardiac RNA-sequencing data from a well-established rat model of HFpEF, the obese and hypertensive ZSF1 rat. With this novel system biology approach, we explored the mechanisms underlying HFpEF. METHODS AND RESULTS: Unlike ZSF1-Lean, ZSF1-Obese and ZSF1-Obese rats fed with a high-fat diet (HFD) developed diastolic dysfunction and reduced exercise capacity. The number of differ...
Background: Exploring the potential biological relationships between heart failure with preserved ej...
BACKGROUND: Information on the pathophysiological differences between heart failure with reduced eje...
Heart failure with preserved ejection fraction (HFpEF) is an emerging disease with signs of nonresol...
Aims: The metabolic syndrome and associated comorbidities, like diabetes, hypertension and obesity, ...
Standard therapies for heart failure with preserved ejection fraction (HFpEF) have been unsuccessful...
Heart failure with preserved ejection fraction (HFpEF) is a common complex clinical syndrome for whi...
BACKGROUND Information on the pathophysiological differences between heart failure with reduced ejec...
Half of all heart failure patients have preserved ejection fraction (HFpEF). Comorbidities associate...
Aims: Despite the high prevalence of heart failure with preserved ejection fraction (HFpEF), the pat...
Lu B, Yu H, Zwartbol M, Ruifrok WP, van Gilst WH, de Boer RA, Sillje HHW. Identification of hypertro...
Background: Exploring the potential biological relationships between heart failure with preserved ej...
BACKGROUND: Information on the pathophysiological differences between heart failure with reduced eje...
Heart failure with preserved ejection fraction (HFpEF) is an emerging disease with signs of nonresol...
Aims: The metabolic syndrome and associated comorbidities, like diabetes, hypertension and obesity, ...
Standard therapies for heart failure with preserved ejection fraction (HFpEF) have been unsuccessful...
Heart failure with preserved ejection fraction (HFpEF) is a common complex clinical syndrome for whi...
BACKGROUND Information on the pathophysiological differences between heart failure with reduced ejec...
Half of all heart failure patients have preserved ejection fraction (HFpEF). Comorbidities associate...
Aims: Despite the high prevalence of heart failure with preserved ejection fraction (HFpEF), the pat...
Lu B, Yu H, Zwartbol M, Ruifrok WP, van Gilst WH, de Boer RA, Sillje HHW. Identification of hypertro...
Background: Exploring the potential biological relationships between heart failure with preserved ej...
BACKGROUND: Information on the pathophysiological differences between heart failure with reduced eje...
Heart failure with preserved ejection fraction (HFpEF) is an emerging disease with signs of nonresol...